Expanded Access to ABBV-706

Sponsor: AbbVie

Expanded Access
Sponsor score: 60

ClinicalTrials ID:NCT07310277

This expanded access program provides ABBV-706, an investigational IV drug, to eligible participants before regulatory approval. Eligibility is determined by a medical doctor based on individual medical history and program criteria. Availability varies by territory, and the potential benefits must outweigh the risks for participation.

Patient Parameters

Program Overview

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-706 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.

Eligibility Criteria

Exclusion Criteria

  • There are other suitable treatment options.
  • The participant qualifies for ongoing clinical trials.

Get This Program In Your Inbox

You can sign up and apply your patients for this program.